Antidepressive agents and suicidal tendencies;Antidepressiva und Suizidalität

Nervenarzt

Volumn 85, Issue 9, 2014, Pages 1108-1116

  Grunder G ^a   Veselinovic T ^a   Paulzen, M ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Adolescents; Aggression; Antidepressants; Selective serotonin reuptake inhibitors; Suicidality

Indexed keywords

ANTIDEPRESSANT AGENT;

COMORBIDITY; DEPRESSION; EVIDENCE BASED MEDICINE; HUMAN; INCIDENCE; INTERNATIONAL COOPERATION; MORTALITY; RISK FACTOR; SUICIDAL IDEATION; SURVIVAL RATE; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; COMORBIDITY; DEPRESSION; EVIDENCE-BASED MEDICINE; HUMANS; INCIDENCE; INTERNATIONALITY; RISK FACTORS; SUICIDAL IDEATION; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84929512616     PISSN: 00282804     EISSN: 14330407     Source Type: Journal    
DOI: 10.1007/s00115-014-4092-9     Document Type: Article

References (41)

1. Bouvy PF, Liem M (2012) Antidepressants and lethal violence in the Netherlands 1994–2008. Psychopharmacology (Berl) 222:499–506
2. Bridge JA, Iyengar S, Salary CB et al (2007) Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA 297:1683–1696
3. Carlsten A, Waern M, Ekedahl A, Ranstam J (2001) Antidepressant medication and suicide in Sweden. Pharmacoepidemiol Drug Saf 10:525–530
4. Dasgupta K (1990) Additional cases of suicidal ideation associated with fluoxetine. Am J Psychiatry 147:1570
5. George DT, Phillips MJ, Lifshitz M et al (2011) Fluoxetine treatment of alcoholic perpetrators of domestic violence: a 12-week, double-blind, randomized, placebo-controlled intervention study. J Clin Psychiatry 72:60–65
6. Gibbons RD, Hur K, Bhaumik DK, Mann JJ (2005) The relationship between antidepressant medication use and rate of suicide. Arch Gen Psychiatry 62:165–172
7. Gibbons RD, Hur K, Brown CH et al (2012) Benefits from antidepressants: synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine. Arch Gen Psychiatry 69:572–579
8. Gibbons RD, Brown CH, Hur K et al (2012) Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine. Arch Gen Psychiatry 69:580–587
9. Grunebaum MF, Ellis SP, Li S et al (2004) Antidepressants and suicide risk in the United States, 1985–1999. J Clin Psychiatry 65:1456–1462
10. Gusmão R1, Quintão S, McDaid D et al (2013) Antidepressant utilization and suicide in Europe: an Ecological Multi-National Study. PLoS One 8:e66455
11. Hall WD, Mant A, Mitchell PB et al (2003) Association between antidepressant prescribing and suicide in Australia, 1991–2000: trend analysis. BMJ 326:1008
12. Hammad TA, Laughren T, Racoosin J (2006) Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry 63:332–339
13. Hawton K, Heeringen K van (2009) Suicide. Lancet 373:1372–1381
14. Heiligenstein JH, Beasley CM Jr, Potvin JH (1993) Fluoxetine not associated with increased aggression in controlled clinical trials. Int Clin Psychopharmacol 8:277–280
15. Hernandez JF, Mantel-Teeuwisse AK, Thiel GJ van et al (2012) A 10-year analysis of the effects of media coverage of regulatory warnings on antidepressant use in The Netherlands and UK. PLoS One 7:e45515
16. Hetrick SE, McKenzie JE, Cox GR et al (2012) Newer generation antidepressants for depressive disorders in children and adolescents. Cochrane Database Syst Rev 11:CD004851. doi:10.1002/14651858.CD004851.pub3
17. Hoover CE (1990) Additional cases of suicidal ideation associated with fluoxetine. Am J Psychiatry 147:1570–1571
18. Hoover CE (1991) Suicidal ideation not associated with fluoxetine. Am J Psychiatry 148:543
19. Isacsson G (2000) Suicide prevention – a medical breakthrough? Acta Psychiatr Scand 102:113–117
20. Isacsson G, Holmgren P, Ahlner J (2005) Selective serotonin reuptake inhibitor antidepressants and the risk of suicide: a controlled forensic database study of 14.857 suicides. Acta Psychiatr Scand 111:286–290
21. Leon AC, Marzuk PM, Tardiff K, Teres JJ (2004) Paroxetine, other antidepressants, and youth suicide in New York City: 1993 through 1998. J Clin Psychiatry 65:915–918
22. Leon AC, Marzuk PM, Tardiff K et al (2006) Antidepressants and youth suicide in New York City, 1999–2002. J Am Acad Child Adolesc Psychiatry 45:1054–1058
23. Leon AC, Marzuk PM, Tardiff K et al (2007) Antidepressants in adult suicides in New York City: 2001–2004. J Clin Psychiatry 68:1399–1403
24. Libby AM, Brent DA, Morrato EH et al (2007) Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs. Am J Psychiatry 164:884–891
25. Libby AM, Orton HD, Valuck RJ (2009) Persisting decline in depression treatment after FDA warnings. Arch Gen Psychiatry 66:633–639
26. Mann JJ, Goodwin FK, O’Brien CP, Robinson DS (1993) Suicidal behavior and psychotropic medication. Accepted as a consensus statement by the ACNP Council, March 2, 1992. Neuropsychopharmacology 8:177–183
27. Mann JJ, Emslie G, Baldessarini RJ et al (2006) ACNP Task Force report on SSRIs and suicidal behavior in youth. Neuropsychopharmacology 31:473–492
28. Masand P, Gupta S, Dewan M (1991) Suicidal ideation related to fluoxetine treatment. N Engl J Med 324:420
29. Middleton N, Gunnell D, Whitley E et al (2001) Secular trends in antidepressant prescribing in the UK, 1975–1998. J Public Health Med 23:262–267
30. Okada F, Okajima K (2001) Violent acts associated with fluvoxamine treatment. J Psychiatry Neurosci 26:339–340
31. Olfson M, Marcus SC, Druss B et al (2002) National trends in the outpatient treatment of depression. JAMA 287:203–209
32. Rihmer Z, Appleby L, Rihmer A, Belso N (2000) Decreasing suicide in Hungary. Br J Psychiatry 177:84
33. Schwabe U, Paffrath D (Hrsg) (2013) Arzneiverordnungsreport. Springer, Heidelberg
34. Simon GE, Savarino J, Operskalski B, Wang PS (2006) Suicide risk during antidepressant treatment. Am J Psychiatry 163:41–47
35. Stone M, Laughren T, Jones ML et al (2009) Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration. BMJ 339:b2880
36. Tardiff K, Marzuk PM, Leon AC (2002) Role of antidepressants in murder and suicide. Am J Psychiatry 159:1248–1249
37. Tauscher-Wisniewski S, Nilsson M, Caldwell C et al (2007) Meta-analysis of aggression and/or hostility-related events in children and adolescents treated with fluoxetine compared with placebo. J Child Adolesc Psychopharmacol 17:713–718
38. Teicher MH, Glod C, Cole JO (1990) Emergence of intense suicidal preoccupation during fluoxetine treatment. Am J Psychiatry 147:207–210
39. Thapar A, Collishaw S, Pine DS, Thapar AK (2012) Depression in adolescence. Lancet 379:1056–1067
40. Tiihonen J, Lönnqvist J, Wahlbeck K et al (2006) Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort. Arch Gen Psychiatry 63:1358–1367
41. Polzer J, Bangs ME, Zhang S et al (2007) Meta-analysis of aggression or hostility events in randomized, controlled clinical trials of atomoxetine for ADHD. Biol Psychiatry 61:713–719